Home / Resources / The Pharmaceutical Industry: 2024 (and Beyond) Predictions

The Pharmaceutical Industry: 2024 (and Beyond) Predictions

Article
Clinical
PDF preview of the 2024 Pharmaceutical Industry Predictions by Citeline.

Do your 2024 predictions for the pharmaceutical industry align with ours? Read on to find out.

Rubber will meet the road on diversity in 2024.
Ashley Schwalje, Senior Director of Clinical Solution Consulting, Citeline
Related products
Aerial shot of a diverse population, key to the success of the Diversity Action Plan.
Sitetrove Diversity Module
Enabling sponsors to optimize investigator selection and hit diversity goals faster
Digital map showcasing the reach of Sitetrove, providing data from trial sites across the globe.
Sitetrove
The industry-leading suite of global clinical trial investigator and site intelligence
Collage of the various Pharma Ignite marketing capabilities supporting the whole product life cycle.
Real-World Data Solutions
Take a patient-centric view of your clinical trial planning and execution by tapping into a diverse, tokenized real world dataset covering over 300 million US lives.

Related resources

PDF preview of the "RWD More than Acronym" article.
OCT 09, 2023
Article

RWD: More Than Just Another Acronym

Real-world data holds the power to impact patient outcomes. Read our article on RWD benefits and how it impacts the patient journey.

MAR 01, 2023
White paper
Clinical

Unlocking the Potential of Decentralized Clinical Trials

While trials with decentralized attributes have grown, we are still in the early stages of adapting trial design strategies to better fit this new reality.

A diverse group of people looking up.
NOV 15, 2023
Article
Clinical

3 Ways Clinical Trial Diversity Can Put Sponsors On Top

Since the FDA’s draft guidance in 2022, the industry has redoubled its efforts to incorporate diversity at pivotal points in the clinical trial process.

View all resources